CNCR vs. HELX ETF Comparison

Comparison of Loncar Cancer Immunotherapy ETF (CNCR) to Franklin Genomic Advancements ETF (HELX)
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description

ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$16.71

Average Daily Volume

39,291

Number of Holdings *

73

* may have additional holdings in another (foreign) market
HELX

Franklin Genomic Advancements ETF

HELX Description Seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life. Provides access to companies benefitting from or facilitating the use of new research including DNA sequencing, gene editing and personalized medicine Uses bottom-up fundamental research conducted by dedicated, industry-specific analysts to identify disruptive business models at the right stage for investment Actively managed by a seasoned portfolio management team that is based in Silicon Valley and has a long history of investing in the craft of innovation

Grade (RS Rating)

Last Trade

$32.76

Average Daily Volume

995

Number of Holdings *

56

* may have additional holdings in another (foreign) market
Performance
Period CNCR HELX
30 Days -1.14% 1.44%
60 Days 17.58% 9.46%
90 Days 18.94% 6.57%
12 Months 37.70% 10.56%
5 Overlapping Holdings
Symbol Grade Weight in CNCR Weight in HELX Overlap
BMY D 0.79% 0.74% 0.74%
BNTX F 0.74% 1.71% 0.74%
REGN B 1.07% 4.54% 1.07%
RXRX D 1.13% 0.47% 0.47%
SDGR F 0.76% 0.5% 0.5%
CNCR Overweight 68 Positions Relative to HELX
Symbol Grade Weight
JANX C 3.67%
YMAB C 3.09%
MRSN D 3.08%
FATE C 3.07%
MGNX D 3.0%
IOVA C 2.65%
RVMD C 2.37%
MOR B 2.04%
AUTL C 1.98%
ACLX C 1.98%
KURA C 1.96%
KYMR C 1.95%
SWTX C 1.78%
MRUS C 1.75%
SMMT D 1.73%
ARVN D 1.62%
BPMC C 1.62%
NUVB B 1.57%
NUVL D 1.53%
INBX D 1.52%
CGEM D 1.49%
IDYA D 1.42%
PRLD C 1.38%
GERN C 1.37%
NRIX C 1.34%
IGMS F 1.26%
SNDX C 1.2%
GLUE C 1.15%
BCYC C 1.13%
TSVT D 1.12%
LYEL F 1.1%
ACET D 1.09%
NGM C 1.08%
IMCR D 1.07%
KPTI C 1.07%
HCM C 1.07%
DCPH D 1.05%
MRK B 1.05%
TYRA D 1.03%
BMEA F 1.02%
ELVN C 1.02%
ALLO C 1.02%
EXEL B 1.0%
XNCR C 1.0%
DAWN D 0.98%
PGEN D 0.93%
FHTX C 0.92%
IMTX D 0.85%
ITOS C 0.84%
AURA F 0.83%
CRBU F 0.82%
STRO D 0.81%
LEGN F 0.8%
RLAY F 0.78%
VOR D 0.77%
ERAS D 0.76%
RCUS C 0.76%
IPHA F 0.75%
GMAB D 0.71%
ACRV D 0.55%
DNA F 0.54%
ZNTL D 0.53%
RPTX F 0.46%
REPL D 0.42%
RAPT F 0.4%
AGEN F 0.39%
IMRX F 0.31%
GNLX F 0.24%
CNCR Underweight 51 Positions Relative to HELX
Symbol Grade Weight
MEDP B -7.44%
TMO C -4.82%
VRTX D -4.64%
LLY B -4.15%
DHR C -3.93%
KRYS C -3.79%
BRKR B -3.41%
CRL B -2.6%
CDNS C -2.35%
NTRA C -2.32%
IONS F -2.31%
AZN C -2.24%
A B -2.18%
CTVA C -2.12%
MRNA C -2.01%
RCKT D -2.0%
EXAS D -1.86%
QGEN F -1.84%
FDMT B -1.73%
SRPT C -1.59%
ICLR C -1.59%
NTLA F -1.45%
ALNY F -1.3%
IQV B -1.19%
AZTA D -1.13%
RGEN D -1.07%
VYGR C -1.03%
LH D -0.96%
CRSP D -0.95%
TECH F -0.89%
NBIX C -0.77%
INSM D -0.76%
TWST D -0.74%
BIO C -0.72%
BEAM C -0.59%
LGND D -0.57%
CDMO F -0.54%
BBIO D -0.52%
AVTR B -0.5%
DVAX F -0.49%
UTHR C -0.49%
RARE D -0.48%
SLP D -0.37%
ARE B -0.31%
DOCS D -0.29%
FTRE B -0.17%
VCYT F -0.15%
TXG F -0.13%
OLK D -0.12%
PACB F -0.09%
GH F -0.09%
Compare ETFs